What are the components of useful, evidence-based data? Dr. Robert Wild discusses with host Dr. Alan Brown the spectrum of data — from expert opinion, to observational studies, to different types of analytic studies, including cross-sectional, case-controlled studies, cohort studies, and clinical trials — and the shortcomings and biases of each. Dr. Wild explores cardiovascular epidemiology, clinical interpretation of biostatistical principles and how to critically evaluate research, in order to better integrate evidence, experience and patient values in clinical decisions.
From Experts to Analytics: What Does Evidence-Based Medicine Mean?

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What are the components of useful, evidence-based data? Dr. Robert Wild discusses with host Dr. Alan Brown the spectrum of data — from expert opinion, to observational studies, to different types of analytic studies, including cross-sectional, case-controlled studies, cohort studies, and clinical trials — and the shortcomings and biases of each. Dr. Wild explores cardiovascular epidemiology, clinical interpretation of biostatistical principles and how to critically evaluate research, in order to better integrate evidence, experience and patient values in clinical decisions.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?